Cognitive Bias Modification - Interpretation training for Anxiety
Study Summary
This trial will compare two methods of delivering cognitive behavioral therapy for insomnia (CBT-I) - via computer or mobile phone - to see which is more effective. They will also test if adding minimal human contact for participants at risk of dropout improves retention and outcomes.
- Anxiety
Treatment Effectiveness
Effectiveness Progress
Study Objectives
4 Primary · 11 Secondary · Reporting Duration: Baseline, and after sessions 1,2, 3, 4, 5 (sessions will be spaced ~1 week apart) & at 2-month follow-up (~2 months after session 5). Session 1 occurs ~0-7 days after baseline. Measure will be completed immediately following that day's training session.
Trial Safety
Safety Progress
Trial Design
4 Treatment Groups
Psychoeducation
1 of 4
CBM-I, high attrition, coach
1 of 4
CBM-I, high attrition, no coach
1 of 4
CBM-I, low attrition
1 of 4
Active Control
Experimental Treatment
840 Total Participants · 4 Treatment Groups
Primary Treatment: Cognitive Bias Modification - Interpretation training · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many people are agreed to be a part of this testing?
"That is correct. The website provides evidence that the trial is presently looking for 840 patients at 1 locations." - Anonymous Online Contributor
Are people still being recruited to participate in this experiment?
"Yes, the most recent data from clinicaltrials.gov suggests that this trial is currently looking for participants. The trial was first posted on 1/20/2019 and updated as recently as 11/8/2022. They are recruiting 840 individuals from a single site." - Anonymous Online Contributor
What are the investigators of this study hoping to discover?
"The primary outcome of this trial will be Change in Recognition Ratings, which will be evaluated over a Baseline, and after session 3 (2-3 weeks following baseline), session 5 (2 weeks after session 3), & at 2-month follow-up ( 2 months after session 5). The secondary outcomes include Change in Depression Comorbid symptoms, Change in Anxiety and Identity Circles, and Change in Mechanisms underlying bias change - Experiential avoidance." - Anonymous Online Contributor
Does the FDA sanction Cognitive Bias Modification - Interpretation training?
"While Phase 2 trials have not yet provided evidence for efficacy, there is some data supporting the safety of Cognitive Bias Modification - Interpretation training. For this reason, our team has given it a score of 2." - Anonymous Online Contributor